J&J cuts the price of its lifesaving TB pill by more than half for many low- and middle-income countries

By STAT News
| August 31, 2023

Advocacy groups continue to argue that Johnson & Johnson, which makes the pill, has stymied wider access.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...